Moloney Securities Asset Management’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,010
Closed -$920K 479
2023
Q4
$920K Buy
2,010
+35
+2% +$17.3K 0.15% 167
2023
Q3
$961K Buy
1,975
+407
+26% +$191K 0.17% 133
2023
Q2
$701K Buy
1,568
+38
+2% +$19.1K 0.12% 199
2023
Q1
$743K Buy
1,530
+221
+17% +$109K 0.14% 178
2022
Q4
$671K Buy
+1,309
New +$688K 0.15% 184
2020
Q3
Sell
-1,003
Closed -$389K 336
2020
Q2
$389K Buy
1,003
+57
+6% +$21.3K 0.11% 181
2020
Q1
$297K Sell
946
-55
-5% -$18.6K 0.11% 190
2019
Q4
$367K Sell
1,001
-297
-23% -$94.2K 0.11% 216
2019
Q3
$332K Buy
+1,298
New +$364K 0.11% 220

Other funds holding HUM

Moloney Securities Asset Management's HUM Position: Q1 2024 in Review

Moloney Securities Asset Management sold out of Humana (HUM) in Q1 2024, closing a stake of 2,010 shares — an estimated $920K sold.

Moloney Securities Asset Management first reported a position in HUM in Q3 2019 and held it in 9 quarters. The position peaked at $961K in Q3 2023. 1,029 funds tracked by Wall St. Rank hold HUM as of Q1 2024.

  • Moloney Securities Asset Management reported no remaining Humana position as of Q1 2024 after selling out during the quarter.
  • Moloney Securities Asset Management sold 2,010 Humana shares in Q1 2024, an estimated $920K.
  • Moloney Securities Asset Management first reported a position in Humana in Q3 2019 and held it in 9 quarters.
  • Moloney Securities Asset Management's Humana position peaked at $961K in Q3 2023.
  • 1,029 funds tracked by Wall St. Rank held Humana as of Q1 2024.

Based on Moloney Securities Asset Management's 13F filing for Q1 2024, filed 1 May 2024.